ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted three newly-hired non-executive employees stock options to purchas…
Author: Business Wire
ADDING MULTIMEDIA Eye Physicians of Libertyville Acquires Northern Illinois Eye Clinic
LIBERTYVILLE, Ill.–(BUSINESS WIRE)–Effective March 28, 2024, Eye Physicians of Libertyville doctors will assume care for Northern Illinois Eye Clinic patients. “Dr. Velotta is a well-respected ophthalmologist in our community, and I wish her the best…
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that i…
Global Sports Optics Analysis 2023: A $2.73 Billion Market by 2029 Featuring Key vendors – Nikon, Swarovski, Beretta, Vortex, Leica Camera, Carlyle group, ATN, and Trijicon Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Sports Optics Market: Analysis By Type, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029” report has been added to ResearchAndMarkets.com’s offering. The global sports optics market value st…
Empowering the Future of Optometry: Axcel Learning Partners with KMK Optometry to Redefine Board Exam Preparation
SAN FRANCISCO & OMAHA, Neb.–(BUSINESS WIRE)–Axcel Learning (Axcel), a professional education business backed by Alpine Investors (Alpine), today announced a new partnership with KMK Optometry (KMK), the premier provider of comprehensive optometry boa…
Aurion Biotech Announces First Canadian Subject Dosed in Phase 1 / 2 Clinical Trial
SEATTLE & CAMBRIDGE, Mass. & TOKYO–(BUSINESS WIRE)–Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced that it has dosed the first Canadian subject in its Phase 1 / 2 c…
Azura Ophthalmics to Present New Data Supporting the Potential of AZR-MD-001 to be the First Ophthalmic Keratolytic for Ocular Surface Diseases
TEL AVIV, Israel–(BUSINESS WIRE)–Azura Ophthalmics Ltd. announced multiple presentations highlighting positive efficacy and safety data from Phase 2 studies of AZR-MD-001.
Aldeyra Therapeutics Announces Clinical Development Plan for Resubmission of New Drug Application for Reproxalap in Dry Eye Disease
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the cli…
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced the pricing o…
Wiregrass Museum of Art to Loan EnChroma Glasses to Color Blind Visitors
DOTHAN, Ala. & BERKELEY, Calif.–(BUSINESS WIRE)– #enchroma–Wiregrass Museum of Art (WMA) and EnChroma® – creators of glasses for color blindness – today announced that WMA will loan EnChroma glasses to visitors who are red-green color blind so they …
Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced fifteen podium and four poster presentations during the American S…
Center For Sight Implants New FDA-Approved iDose®TR Device
SARASOTA, Fla.–(BUSINESS WIRE)– #Eyecare–Center For Sight, A US Eye Company, one of the nation’s leading ophthalmology practices, has performed the first iDoseTR implant surgery in the state of Florida since the device was approved by the Food and D…
Stoke Therapeutics Announces Proposed Public Offering
BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced a proposed un…
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and 12 months ended December 31, 2023 and provides a business update. “Quarterly revenue from our eyecare and wound care se…
NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2023 after market close on Tuesday, March 26, 2024 and will hold an …
MyEyeDr. Partners with Prevent Blindness to Promote Eye Health and Safety During April 8 Solar Eclipse, Gives Away Solar Glasses at 400+ Locations
VIENNA, Va.–(BUSINESS WIRE)–Ahead of the total solar eclipse on Monday, April 8, MyEyeDr., a leading provider of eye health services with over 800 locations across the U.S., is educating consumers about the importance of eye health and the need for p…
Translational Vision Science and Technology Journal Publishes RadiusXR's NOVA Clinical Trial, Demonstrating Industry-Leading Accuracy and Innovation in Visual Field Testing for Virtual Reality Perimetry
PLEASANTON, Calif.–(BUSINESS WIRE)– #Ophthalmology–RadiusXR, the trailblazer in Digital Health, announces the publication of its groundbreaking NOVA Clinical Trial in Translational Vision Science and Technology (TVST), a prestigious journal by the A…
Horus Pharma Renews Its Partnership With Plastic Bank
NICE, France–(BUSINESS WIRE)–Horus Pharma, an independent French laboratory specialised in ophthalmology known for its expertise in developing preservative-free products designed to facilitate eye and eyelid health, has extended its successful collab…
GenSight Biologics Reports Full Year 2023 Consolidated Financial Results
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress
SAN DIEGO–(BUSINESS WIRE)–LENZ Therapeutics, Inc. (Nasdaq: LENZ) (LENZ or the Company), a late clinical-stage biopharmaceutical company focused on developing the first aceclidine-based eye drop that has been shown to improve near vision in people wit…